Different IVIG glycoforms affect in vitro inhibition of anti-ganglioside antibody-mediated complement deposition.
about
Comparison of Fc N-Glycosylation of Pharmaceutical Products of Intravenous Immunoglobulin GStreptococcal IdeS: therapeutic potential for Guillain-Barré syndrome.Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxiaNeurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy.Regulatory T cell frequency, but not plasma IL-33 levels, represents potential immunological biomarker to predict clinical response to intravenous immunoglobulin therapy.IVIG-mediated effector functions in autoimmune and inflammatory diseases.Biological roles of glycans.Sialylated IgG-Fc: a novel biomarker of chronic inflammatory demyelinating polyneuropathy.Association of neurofascin IgG4 and atypical chronic inflammatory demyelinating polyneuropathy: A systematic review and meta-analysis
P2860
Q35803387-BA1E97BA-5293-415D-AFE0-9957556CC7ACQ35868924-94C8282A-7C7E-482C-BA00-BD6115E3EC5BQ36186804-04EE4D20-2629-4034-A349-75EF34FADE97Q36691991-3E60807D-D0DF-465D-936E-F800EA002438Q37713650-D03A6FDC-B728-49EF-BD6B-F5268B15C8BBQ38699812-936AC373-7060-4254-A088-96091E8DBEE6Q38936714-E5B143D8-044C-4834-B43C-7A584C17487BQ48210931-523830D1-566A-42EC-8699-015896B64308Q58702983-D6513CA1-96DA-40A0-BA08-A898517D712B
P2860
Different IVIG glycoforms affect in vitro inhibition of anti-ganglioside antibody-mediated complement deposition.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Different IVIG glycoforms affe ...... ediated complement deposition.
@ast
Different IVIG glycoforms affe ...... ediated complement deposition.
@en
Different IVIG glycoforms affe ...... ediated complement deposition.
@nl
type
label
Different IVIG glycoforms affe ...... ediated complement deposition.
@ast
Different IVIG glycoforms affe ...... ediated complement deposition.
@en
Different IVIG glycoforms affe ...... ediated complement deposition.
@nl
prefLabel
Different IVIG glycoforms affe ...... ediated complement deposition.
@ast
Different IVIG glycoforms affe ...... ediated complement deposition.
@en
Different IVIG glycoforms affe ...... ediated complement deposition.
@nl
P2093
P2860
P1433
P1476
Different IVIG glycoforms affe ...... ediated complement deposition.
@en
P2093
Benjamin K Ong
Kana Matsumoto-Morita
Makoto Sudo
Nortina Shahrizaila
Peter J Späth
Yoshiki Yamaguchi
P2860
P304
P356
10.1371/JOURNAL.PONE.0107772
P407
P577
2014-09-26T00:00:00Z